Related Experiment Video
Updated: Aug 8, 2026

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
Published on: June 23, 2023
Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and
Paula M Keeney1, Jing Xie, Roderick A Capaldi
1Center for the Study of Neurodegenerative Diseases, University of Virginia, Charlottesville, Virginia 22908, USA.
Abstract:
Loss of mitochondrial complex I catalytic activity in the electron transport chain (ETC) is found in multiple tissues from individuals with sporadic Parkinson's disease (PD) and is a property of some PD model neurotoxins. Using special ETC subunit-specific and complex I immunocapture antibodies directed against the entire complex I macroassembly, we quantified ETC proteins and protein oxidation of complex I subunits in brain mitochondria from 10 PD and 12 age-matched control (CTL) samples. We measured nicotinamide adenine dinucleotide (NADH)-driven electron transfer rates through complex I and correlated these with complex I subunit oxidation levels and reductions of its 8 kDa subunit. PD brain complex I shows 11% increase in ND6, 34% decrease in its 8 kDa subunit and contains 47% more protein carbonyls localized to catalytic subunits coded for by mitochondrial and nuclear genomes We found no changes in levels of ETC proteins from complexes II-V. Oxidative damage patterns to PD complex I are reproduced by incubation of CTL brain mitochondria with NADH in the presence of rotenone but not by exogenous oxidant. NADH-driven electron transfer rates through complex I inversely correlate with complex I protein oxidation status and positively correlate with reduction in PD 8 kDa subunit. Reduced complex I function in PD brain mitochondria appears to arise from oxidation of its catalytic subunits from internal processes, not from external oxidative stress, and correlates with complex I misassembly. This complex I auto-oxidation may derive from abnormalities in mitochondrial or nuclear encoded subunits, complex I assembly factors, rotenone-like complex I toxins, or some combination.
Insights
Parkinson's disease (PD) involves mitochondrial complex I dysfunction. This study found that PD brain complex I shows increased oxidation and misassembly, suggesting internal auto-oxidation rather than external oxidative stress contributes to neurodegeneration.
Area of Science:
- Neuroscience
- Mitochondrial Biology
- Biochemistry
Background:
- Mitochondrial complex I (CI) dysfunction is implicated in sporadic Parkinson's disease (PD).
- CI catalytic activity loss is observed in PD tissues and by PD-associated neurotoxins.
Purpose of the Study:
- To quantify electron transport chain (ETC) proteins and complex I subunit oxidation in PD brain mitochondria.
- To investigate the relationship between CI function, protein oxidation, and subunit levels in PD.
Main Methods:
- Utilized subunit-specific antibodies for immunocapture of the entire complex I macroassembly.
- Quantified ETC proteins and protein oxidation (carbonyls) in mitochondria from PD and control brains.
- Measured NADH-driven electron transfer rates and correlated them with oxidation and subunit levels.
Main Results:
- PD brain CI exhibited increased ND6 (11%), decreased 8 kDa subunit (34%), and 47% more protein carbonyls on catalytic subunits.
- No significant changes were found in ETC complexes II-V protein levels.
- CI function inversely correlated with protein oxidation and positively with 8 kDa subunit reduction.
Conclusions:
- Reduced CI function in PD brains stems from internal auto-oxidation of catalytic subunits, not external oxidative stress.
- CI misassembly correlates with this auto-oxidation, potentially due to genetic factors or toxins.
- Findings suggest internal mitochondrial processes contribute to PD pathogenesis.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Parkinson Disease l: Introduction
Parkinson's Disease: Overview
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
ATP Synthase: Mechanism
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

